Impact of a Standardized Titration Protocol with Carvedilol in Heart Failure: Safety, Tolerability, and Efficacy—A Report from the GESICA Registry

Author： Nul Daniel   Zambrano Carola   Diaz Alejandro   Ferrante Daniel   Varini Sergio   Soifer Saúl   Grancelli Hugo  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.19, Iss.2, 2005-03, pp. : 125-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do Standardized Beta-Blocker Titration Protocols in Heart Failure Improve Compliance? The GESICA Registry Experience

By Remme Willem  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 2, 2005-03 ,pp. : 99-101

Springer Publishing Company

Access to resources Recommend Favorite

Diuretics in Heart Failure: A Critical Appraisal of Efficacy and Tolerability

By Szady Anita D.   Hill James A.  

Drugs, Vol. 69, Iss. 17, 2009-12 ,pp. : 2451-2461

Adis International

Access to resources Recommend Favorite

Carvedilol in the treatment of chronic heart failure

By Moe G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 831-843

Informa Healthcare

Access to resources Recommend Favorite

Rationale and Design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study

By  

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 164-166

Karger

Access to resources Recommend Favorite

COPERNICUS: carvedilol heaven-sent in severe heart failure

By  

Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite